Please select a publication to download. All documents are in PDF format.
September 2021
Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs
June 2020
Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8+ T Cells to Memory T Cells
February 2017
Tracking the fate and origin of clinically relevant adoptively transferred CD8+ T cells in vivo
November 2016
T-Cell Therapy Using Interleukin-21–Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression
June 2016
Combined IL-21–primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma
in a patient
January 2014
Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I
February 2013
Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
June 2008
Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
August 2005
IL-21 Influences the Frequency, Phenotype, and Affinity of the Antigen-Specific CD8 T Cell Response1